Skip to main
RTTR

Ritter Pharmaceuticals (RTTR) P/E Ratio

P/E Ratio as of Dec 24, 2025: -0.31

Average-0.2952
Median-0.2900
Minimum-0.3300
Maximum-0.2600
-0.31
0.01 (3.33%)past month
The P/E ratio for Ritter Pharmaceuticals (RTTR) is -0.31 as of Dec 24, 2025. This represents a increase of 82.35% compared to its 12-month average P/E ratio of -0.17. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Ritter Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Ritter Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Ritter Pharmaceuticals to industry peers.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Ritter Pharmaceuticals (RTTR) P/E Ratio Historic Data

DateStock priceP/E ratio
Dec 1, 2025$2.35-0.27
Nov 3, 2025$2.81-0.32
Oct 1, 2025$6.01-0.69
Sep 2, 2025$1.79-0.21
Aug 1, 2025$2.17-0.12
Jul 1, 2025$3.32-0.10
Jun 2, 2025$3.92-0.07
May 1, 2025$3.52-0.06
Apr 1, 2025$3.49-0.06
Mar 3, 2025$3.10-0.06
Feb 3, 2025$3.50-0.06
Jan 2, 2025$4.2014-0.08

Ritter Pharmaceuticals (RTTR) End of Year P/E Ratio

DateP/E ratioChange
2025-0.31+287.50%
2024-0.08-46.67%
2023-0.15-37.50%
2022-0.24-86.29%
2021-1.75-99.67%
2020-527.29

FAQs About Ritter Pharmaceuticals (RTTR) P/E ratio

The latest P/E ratio of Ritter Pharmaceuticals (RTTR) is -0.31, as of Dec 24, 2025. This is calculated based on its current stock price and earnings per share (EPS).

Ritter Pharmaceuticals’s last 12-month average P/E ratio is -0.17, compared to its current P/E ratio of -0.31. This reflects a increase of 82.35%.

Ritter Pharmaceuticals’s current P/E ratio of -0.31 is higher than its last 12-month average P/E of -0.17. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Ritter Pharmaceuticals’s average P/E ratio over the last 3 years is -0.19. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Ritter Pharmaceuticals’s average P/E ratio over the last 5 years is -76.3. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Ritter Pharmaceuticals (RTTR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.